Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Bateman: Meta-analysis: effects of adding salmeterol to inhaled corticosteroids on serious.... (0.09 sec) 

Meta-analysis: effects of adding salmeterol to inhaled corticosteroids on serious asthma- …

- annals.org [PDF] 
E Bateman, H Nelson, J Bousquet, K Kral, L … - Annals of Internal Medicine, 2008 - Am Coll Physicians
Purpose: To examine whether the incidences of severe asthma- related events
(hospitalizations, intubations, deaths, and severe ex- acerbations) differ in
persons receiving salmeterol plus inhaled cor- ticosteroids compared with ...
Cited by 20 - Related articles - All 7 versions

Regular treatment with formoterol for chronic asthma: serious adverse events.


CJ Cates, MJ Cates, TJ Lasserson - Cochrane database of systematic reviews (Online), 2008 - ncbi.nlm.nih.gov
BACKGROUND: Epidemiological evidence has suggested a link between beta-agonists
and increases in asthma mortality. There has been much debate about possible
causal links for this association, and whether regular (daily) long-acting ...
Cited by 13 - Related articles - All 2 versions

An observational study of fixed dose combination fluticasone propionate/salmeterol or …


RH Stanford, A Fuhlbrigge, A Riedel, GG Rey … - Current Medical Research and Opinion®, 2008 - informahealthcare.com
Methods: A retrospective, observational cohort analysis evaluated pharmacy and
medical claims from subjects from a commercial managed-care database, which is
similar in makeup to the US privately insured population, with a diagnosis ...
Cited by 1 - Related articles - All 5 versions

Long-acting {beta}-agonists: a review of formoterol safety data from asthma clinical trials

- ersj.org.uk
MR Sears, A Ottosson, F Radner, S Suissa - European Respiratory Journal, 2009 - Eur Respiratory Soc
There were eight asthma-related deaths (0.34 per 1,000 person-yrs) among 49,906
formoterol-randomised patients (92% using ICS), and two (0.22 per 1,000
person-yrs) among 18,098 patients (83% using ICS) not randomised to ...
Cited by 15 - Related articles - All 6 versions

{beta} 2-Adrenoceptor polymorphisms and asthma phenotypes: interactions with passive …

- ersjournals.com
G Zhang, CM Hayden, SK Khoo, P Candelaria, IA … - European Respiratory Journal, 2007 - Eur Respiratory Soc
Among children exposed to tobacco smoke, those with Arg16 (at least one Arg
allele) exhibited lower adjusted mean FEV 1 (2.19 versus 2.38 L) and FVC (2.43
versus 2.64 L) than Gly16 homozygotes. Those with Gln27 (at least one Gln ...
Cited by 13 - Related articles - BL Direct - All 7 versions

Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in …

- siaip.it [PDF] 
J Maspero, F Guerra, F Cuevas, JP Gutierrez … - Clinical therapeutics, 2008 - Elsevier
Methods: Children with asthma (forced expiratory volume in 1 second [FEV 1 ]
55%–80% predicted; reversibility ≥12%) aged 6 to 14 years who were receiving
only short-acting β 2 -agonists entered a 2-week run-in period. ...
Cited by 2 - Related articles - All 5 versions

[CITATION] long-acting ß2 agonists


M Asthma - Accessed from www. mhra. gov. uk/Safetyinformation/ …
Cited by 2 - Related articles

[CITATION] Clinical Knowledge Summaries, 2007


CKS Asthma - Accessed from http://www. cks. library. nhs. uk/asthma …
Cited by 2 - Related articles

The Arg16Glybeta2-adrenergic receptor polymorphism influences long term clinical …


A Isada, N Hizawa, K Shimizu, A Takahashi, T … - Arerugī=[Allergy], 2008 - ncbi.nlm.nih.gov
BACKGROUND: The coding region variant Arg16Gly at the beta2-adrenoceptor gene
(ADRB2) is functionally relevant, and is common in Japanese. Longer term
clinical responses to short-acting and long-acting beta2 agonists have been ...
Cited by 2 - Related articles

Use of salmeterol with and without concurrent use of inhaled corticosteroids and the risk of …


MT Wang, GH Skrepnek, E Armstrong, DL … - Current Medical Research and Opinion®, 2008 - informahealthcare.com
Rationale: Studies evaluating the safety of salmeterol are inconclusive, which
might be the result from not taking into account the impact of concomitant
inhaled corti costeroids (ICS). Objective: To study whether salmeterol use ...
Cited by 2 - Related articles - BL Direct - All 6 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google